Showcase your innovation to active life science investors
By Max Braht, Director of Business Development, LSN
Life Science Nation (LSN) is now accepting applications for the Innovator’s Pitch Challenge (IPC) at both RESI London and RESI JPM. The IPC provides early-stage life science and healthcare companies with the opportunity to pitch directly to a panel of active investors, receive interactive feedback, and showcase their technology in the RESI Exhibition Hall.
RESI London – December 2025
The first week of December marks the largest life science partnering and venture week in the UK. For companies raising pre-seed through Series B, or those in Phase II or earlier development, RESI London—alongside One Nucleus’ Genesis and ELRIG/SLAS events—offers a stronger fit compared to the late November healthcare week held concurrently with Jefferies. While Jefferies tends to focus on IPO-ready or Phase III+ companies, RESI London is designed for venture-stage entrepreneurs seeking investment and strategic partnerships.
The conference takes place in person on December 4 at No.11 Cavendish Square, London, with virtual partnering continuing on December 8–9.
Apply to Pitch at RESI London >>
Application Deadline: Friday, October 24
RESI JPM – January 2026
The RESI Conference will return to San Francisco during JP Morgan Healthcare Week, providing entrepreneurs with access to the largest gathering of early-stage life science investors in the world. Taking place January 12–13 at the Marriott Marquis San Francisco, the conference will be followed by three days of virtual partnering on January 14, 19, and 20.
RESI JPM draws more than a thousand participants, including 500+ global investors, innovators, and industry experts. The Innovator’s Pitch Challenge allows selected companies to pitch live, engage in Q&A with investors, and participate in dedicated partnering meetings throughout the week.
Application Deadline: Wednesday, November 12
Apply today to secure your place in the Innovator’s Pitch Challenge at RESI London or RESI JPM and take advantage of the opportunity to showcase your innovation directly to active investors.
Next Phase Newsletter 
Leave a comment